- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06338449
The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver Disease
The purpose of this clinical trial is to investigate which exercise regimen is more effective in improving non-alcoholic fatty liver disease (NAFLD) in a young population. The primary questions it aims to answer are:
Does aerobic training, resistance training, or a combination of both help improve liver function and glycemic and lipid parameters in NAFLD patients? Which of these three exercise regimens is more effective in improving the aforementioned parameters? Is the improvement in liver function related to bile acid metabolism?
Participants will:
Engage in physical exercise 4-5 times per week for two consecutive months, following a predefined exercise regimen.
Have blood samples collected to test for glucose, lipids, liver function, and other parameters before starting the exercise program and after two months of completing the regimen.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Jiangsu
-
Xuzhou, Jiangsu, China, 221000
- Outdoor track and field facility of Xuzhou Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Body fat percentage >20% or BMI >24
- The diagnostic result of abdominal ultrasonography is fatty liver
- No regular exercise under guidance in the past 3 months
- No medication taken in the last month
- No binge eating or heavy drinking in the past two weeks
Exclusion Criteria:
- Long history of alcohol consumption, equivalent to more than 30g/day of ethanol
- Viral hepatitis
- History of autoimmune or genetic diseases
- History of drug-induced liver disease
- History of total parenteral nutrition
- History of cardiovascular, respiratory, or other diseases that necessitate avoidance of intense physical activity.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Aerobic training (AT)
Aerobic exercise can include activities like swimming, running, or cycling.
Scientifically, aerobic exercise is defined as any activity that uses large muscle groups, can be maintained continuously, and is rhythmic in nature.
It improves the efficiency of the cardiovascular, respiratory, and circulatory systems by delivering oxygen more efficiently to the body.
According to reports, aerobic exercise can help reduce fat and improve liver function.
|
An exercise program was developed by a full-time physical education teacher, with all group exercises conducted at the outdoor track and field facility of Xuzhou Medical University.
Participants in the aerobic training group, after completing a warm-up, were required to perform moderate-intensity aerobic running for 60 minutes per session, 4-5 times a week.
The exercise intensity was set to reach 50%-70% of the maximum heart rate (Maximum heart rate = 220 - age).
The exercise sessions were scheduled in the evening after dinner, from 17:30 to 19:00.All participants were continuously intervened for 8 weeks.
|
Active Comparator: Resistance training (RT)
Resistance exercise is a form of physical activity that is designed to improve muscular fitness by exercising a muscle or a muscle group against external resistance.
This includes traditional weightlifting, using weight machines, resistance band exercises, bodyweight exercises, and other activities designed to build muscle strength, endurance, and size.
The key principle is the muscle's ability to contract against resistance: using weights, resistance bands, or one's own body weight, the muscle is challenged, leading to muscular adaptation and growth, enhancing strength and endurance.
According to reports, resistance exercise can also help improve liver function.
|
Participants in the resistance training group were required to complete moderate-intensity resistance exercises 4-5 times per week.
Each session included a warm-up, followed by exercises such as knee lifts with torso twists, knee-to-hand taps under the hips, jumping jacks, burpees, sit-ups, planks, and squats.
The routine was structured to perform 5-6 exercises per session, with 6-8 repetitions for each set.
There was a 30-second rest interval between sets, and the total exercise time was 60 minutes.
The timing for these exercise sessions was the same as for the AT group, conducted in the evening after dinner.All participants were continuously intervened for 8 weeks.
|
Active Comparator: Combined aerobic and resistance training (AT + RT)
The combination of aerobic exercise and resistance exercise.
|
Participants in the combined aerobic and resistance training (AT+RT) group started their sessions with a warm-up, followed by 30 minutes of aerobic running.
After the aerobic training, they engaged in resistance training.
The resistance training regimen was the same as that for the RT group, except that the duration of the resistance training was shorter.
The total duration of the exercise session was 60 minutes.All participants were continuously intervened for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in body weight compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in Body Mass Index compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
BMI
|
Baseline and 8 weeks
|
Changes in total cholesterol compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in triglycerides compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in high-density lipoprotein compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in low-density lipoprotein compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in alanine aminotransferase compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in aspartate aminotransferase compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in alkaline phosphatase compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in gamma-glutamyl transferase compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in direct bilirubin compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in total bile acids compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
|
Changes in adenosine deaminase compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in percentage of body fat compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Changes in waist-to-hip ratio compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Changes in blood glucose compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Changes in the level of insulin compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Changes in albumin compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Changes in C-reactive protein compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in other subtypes of bile acids compared to baseline at 8 weeks
Time Frame: Baseline and 8 weeks
|
Baseline and 8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- XZMU-2022-ZK068
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-alcoholic Fatty Liver Disease NAFLD
-
Ann & Robert H Lurie Children's Hospital of ChicagoNot yet recruitingNAFLD | Non-Alcoholic Fatty Liver Disease | Pediatric NAFLDUnited States
-
Medical College of WisconsinENDRA Life Sciences, Inc.RecruitingFatty Liver | NAFLD | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non-alcoholic Fatty Liver | NASH | Fatty Liver DiseaseUnited States
-
Michael Ohliger, MD PhDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingNAFLD | Non-Alcoholic Fatty Liver Disease | NASH | Non Alcoholic Fatty Liver | Non Alcoholic SteatohepatitisUnited States
-
National University Hospital, SingaporeWilmar InternationalEnrolling by invitationNAFLD | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic SteatohepatitisSingapore
-
University of California, DavisNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States
-
Hoffmann-La RocheCompletedFatty Liver, Non-alcoholic Fatty Liver Disease, NAFLDGermany, Austria
-
Mylan Inc.Meda Pharma S.p.A.Recruiting
-
Sohag UniversityNot yet recruitingNon-alcoholic Fatty Liver Disease NAFLD
-
Bruce A. GriffinImperial College London; University of CambridgeCompletedNon-alcoholic Fatty Liver Disease (NAFLD)United Kingdom
-
University of Southern CaliforniaWithdrawnNon-alcoholic Fatty Liver Disease (NAFLD)United States
Clinical Trials on Aerobic training (AT)
-
University of CalgaryUnknownType 2 DiabetesCanada
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Breast CarcinomaUnited States
-
University of PittsburghCompletedCardiovascular Diseases | ObesityUnited States
-
Universidade Federal de Sao CarlosConselho Nacional de Desenvolvimento Científico e TecnológicoCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Fundacao ChampalimaudUniversity of LisbonRecruiting
-
Istanbul University - Cerrahpasa (IUC)CompletedKnee OsteoarthritisTurkey
-
National Taiwan University HospitalRecruitingAgility Training on Executive Function, Dual Task Performance and Brain Activation in Healthy AdultsExecutive Function | Agility TrainingTaiwan
-
Riphah International UniversityRecruiting
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingCancer | Covid19 | CoronavirusUnited States
-
University of BarcelonaCompleted